Global Search

Search articles, concepts, and chapters

Pistilli Maxwell

14 articles in GJC

14 articles in GJC

1.

Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors.

Roldan Ana M, Zebardast Nazlee, Pistilli Maxwell, Khachatryan Naira, Payal Abhishek, Begum Hosne et al.

Am J OphthalmolNov 202111 citationsCohort Study

This study found corneal endothelial transplantation is rare in uveitis patients (1.1% in 10 years), but age, anterior inflammation, prior surgeries (cataract, tube shunt), band keratopathy, and hypotony significantly increase risk, indicating endothelial damage.

3.

The sensitivity and specificity of retinal and choroidal folds to distinguish between mild papilloedema and pseudopapilledema.

Reggie Sara N, Avery Robert A, Bavinger James C, Jivraj Imran, Alfaro Cesar, Pistilli Maxwell et al.

Eye (Lond)Jan 202110 citationsCross-Sectional Study

OCT-detected retinal/choroidal folds were studied to differentiate mild papilledema from pseudopapilledema. Folds were common in papilledema but rare in pseudopapilledema, suggesting their presence indicates true papilledema.

7.

Fluorometholone 0.1% as Ancillary Therapy for Trachomatous Trichiasis Surgery: Randomized Clinical Trial.

Kempen John H, Tekle-Haimanot Redda, Hunduma Lelisa, Alemayehu Menilik, Pistilli Maxwell, Abashawl Aida et al.

Am J OphthalmolSep 20180 citationsRandomized Controlled Trial

Fluorometholone 0.1% eye drops after trachomatous trichiasis surgery appear safe and reduce postoperative recurrence, with twice-daily dosing for four weeks being most promising, warranting further study.

8.

The MT-CO1 V83I Polymorphism is a Risk Factor for Primary Open-Angle Glaucoma in African American Men.

Collins David W, Gudiseva Harini V, Chavali Venkata R M, Trachtman Benjamin, Ramakrishnan Meera, Merritt William T et al.

Invest Ophthalmol Vis SciApr 201822 citationsCase-Control Study

The MT-CO1 V83I polymorphism significantly increases primary open-angle glaucoma risk in African American men, disrupting a protein interaction, suggesting a sex-specific genetic factor for this disease.

14.

A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab.

Wehrli Sarah J, Tawse Kirstin, Levin Marc H, Zaidi Ali, Pistilli Maxwell, Brucker Alexander J

RetinaJul 201266 citationsRetrospective Chart Review

This study found anti-VEGF injections for AMD did not significantly increase delayed IOP elevation risk in injected eyes compared to control eyes, including those with glaucoma, suggesting low long-term IOP risk.

All 14 articles loaded